This is a Validated Antibody Database (VAD) review about cow YAP1, based on 72 published articles (read how Labome selects the articles), using YAP1 antibody in all methods. It is aimed to help Labome visitors find the most suited YAP1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
YAP1 synonym: transcriptional coactivator YAP1; Yes-associated protein 1, 65kDa; yorkie homolog

Knockout validation
Cell Signaling Technology
rabbit polyclonal
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on mouse samples at 1:500 (fig 4d). Exp Mol Med (2018) ncbi
Cell Signaling Technology
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 3a). Cancer Manag Res (2019) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1f
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in western blot on human samples (fig 1f). Curr Biol (2019) ncbi
rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 1b
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:500 (fig 1b). Nat Commun (2018) ncbi
rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 5c). J Cell Sci (2018) ncbi
rabbit polyclonal
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot knockout validation on mouse samples at 1:500 (fig 4d). Exp Mol Med (2018) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 8c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 8c). J Clin Invest (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2a). Cancer Res (2017) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1fs2
In order to test the role of YAP in branching morphogenesis for tissue patterning, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in immunohistochemistry on mouse samples at 1:100 (fig 1fs2). elife (2017) ncbi
rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology YAP1 antibody (CST, 4911) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4e
In order to find that that Fat4 modulates Hippo signaling and restricts hearth growth in mice, Cell Signaling Technology YAP1 antibody (Cell signalling, 4911) was used in western blot on mouse samples at 1:1000 (fig 4e). Nat Commun (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 3c
In order to find that frictional force characteristic of flow in the lymphatics stimulates YAP1 to drive cancer cell migration, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 3c). Nat Commun (2017) ncbi
rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig 3b
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on mouse samples at 1:500 (fig 3b). J Clin Invest (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig s4a
In order to report that DUB3 family deubiquitylating enzymes regulate Hippo pathway activity, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s4a). PLoS ONE (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3b
  • western blot; mouse; 1:500; loading ...; fig 3a
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 3b) and in western blot on mouse samples at 1:500 (fig 3a). Nat Commun (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 1i
  • western blot; mouse; 1:1000; loading ...; fig 1b
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 1i) and in western blot on mouse samples at 1:1000 (fig 1b). Nature (2016) ncbi
rabbit polyclonal
  • western blot; mouse; fig 1a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 1a). Cell (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig s2f
In order to demonstrate that the Hippo, Wnt/beta-catenin, and Notch pathways interact to regulate liver size and inhibit hepatocellular carcinoma, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s2f). J Clin Invest (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 1a
  • western blot; mouse; 1:1000; loading ...; fig 1g
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 1a) and in western blot on mouse samples at 1:1000 (fig 1g). Gastroenterology (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 5h
Cell Signaling Technology YAP1 antibody (cell signalling, 4911) was used in western blot on human samples (fig 5h). J Clin Invest (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:100; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:100 (fig st1). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 5A
In order to explore the role of NHERF1 in intestinal adenoma development, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5A). Neoplasia (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 2
  • western blot; mouse; fig 2
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2) and in western blot on mouse samples (fig 2). Sci Rep (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:500; loading ...; fig 4e
  • western blot; rat; loading ...; fig 4c
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunohistochemistry - paraffin section on rat samples at 1:500 (fig 4e) and in western blot on rat samples (fig 4c). PLoS ONE (2016) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:150; fig 6
  • western blot; mouse; 1:2000; fig s3
In order to investigate the roles of NF2, LATS1/2, and YAP in the branching morphogenesis of the mouse kidney, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunohistochemistry on mouse samples at 1:150 (fig 6) and in western blot on mouse samples at 1:2000 (fig s3). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4
In order to investigate mechanisms that regulate myelin growth and nerve conduction, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 7g
In order to study interaction between the p38 mitogen-activated protein kinase pathway and the Hippo pathway, Cell Signaling Technology YAP1 antibody (Cell Signalling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 7g). J Mol Cell Biol (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 1a). J Biol Chem (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 7c
In order to investigate the contribution of YAP in mouse neocortical astrocytic differentiation and proliferation, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 7c). Development (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3d
  • western blot; rat; 1:1000; loading ...; fig 3d
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 3d) and in western blot on rat samples at 1:1000 (fig 3d). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 1
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples (fig 1). J Biol Chem (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 5
In order to study the production of a dominantly-acting oncogene in human breast cancer due to premature polyadenylation of MAGI3, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 5). elife (2016) ncbi
rabbit polyclonal
  • western blot; chicken; 1:1000; fig 7
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in western blot on chicken samples at 1:1000 (fig 7). BMC Biol (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 5
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911S) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 5). Front Physiol (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 2d
In order to study GSK3 inhibitor BIS I, YAP-dependent EMT signature in PDAC cell lines, and SMADs expression level, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2d). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; mouse; fig 5
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 5). J Biol Chem (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples at 1:1000 (fig 1). Nat Commun (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:50; fig 6
  • immunocytochemistry; human; 1:50; fig 6
In order to report that NEK8 human mutations cause major organ developmental defects, altered ciliogenesis, disrupted cell differentiation and proliferation, and deregulation of the Hippo pathway, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in immunocytochemistry on mouse samples at 1:50 (fig 6) and in immunocytochemistry on human samples at 1:50 (fig 6). PLoS Genet (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 4
In order to study the interaction with YAP1 in aggressive cancer types by ZEB1 turning into a transcriptional activator, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples at 1:1000 (fig 4). Nat Commun (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 4
In order to investigate Tead4-mediated transcriptional networks in various types of cancer cells, Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples (fig 4). Cell Rep (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 2
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig 2). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; mouse; fig 4
  • western blot; human; fig 7
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 4) and in western blot on human samples (fig 7). Proc Natl Acad Sci U S A (2016) ncbi
rabbit polyclonal
  • western blot; mouse; fig 5
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples (fig 5). J Cell Biol (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to study the activation mechanisms of core Hippo pathway components, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples (fig 3). EMBO Rep (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:2000; fig 1
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples at 1:2000 (fig 1). Nat Commun (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig s3
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig s3). Sci Rep (2015) ncbi
rabbit polyclonal
  • western blot; mouse
In order to investigate junctional intercellular communication, mechanotransduction through cytoskeletal organization, and the hippo-YAP pathway in cardiac damage caused by direct exposure to ethanol, Cell Signaling Technology YAP1 antibody (Cell Signaling, #4911) was used in western blot on mouse samples . PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; dog; 1:1000; fig 3e
In order to assess the contribution of aPKC to epithelial cell transformation, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911S) was used in western blot on dog samples at 1:1000 (fig 3e). Mol Biol Cell (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 6
  • western blot; human; 1:1000; fig s2
Cell Signaling Technology YAP1 antibody (Cell Signaling Tech, 4911) was used in western blot on mouse samples at 1:1000 (fig 6) and in western blot on human samples at 1:1000 (fig s2). PLoS ONE (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig 7
  • western blot; human; 1:500; fig 7
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunocytochemistry on human samples at 1:100 (fig 7) and in western blot on human samples at 1:500 (fig 7). Nat Commun (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000. Oncogene (2016) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 5
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 5). Nat Cell Biol (2015) ncbi
rabbit polyclonal
  • western blot; human; fig s6
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s6). EMBO J (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on human samples at 1:1000 (fig 2). J Oral Pathol Med (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples at 1:1000 (fig 5). Nat Cell Biol (2015) ncbi
rabbit polyclonal
  • western blot; human
In order to identify binding partners ANKHD1 in leukemia cells, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911S) was used in western blot on human samples . Biochim Biophys Acta (2015) ncbi
rabbit polyclonal
  • western blot; mouse; fig 6j
  • western blot; human; fig 6i
Cell Signaling Technology YAP1 antibody (Cell signaling, 4911) was used in western blot on mouse samples (fig 6j) and in western blot on human samples (fig 6i). Dev Cell (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:100; fig 4
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunohistochemistry on human samples at 1:100 (fig 4) and in western blot on human samples at 1:1000 (fig 3). Nat Cell Biol (2015) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:200
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunohistochemistry on mouse samples at 1:200. Dev Biol (2015) ncbi
rabbit polyclonal
  • western blot; human; fig s6
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on human samples (fig s6). Nat Commun (2014) ncbi
rabbit polyclonal
  • western blot; rat; fig 3
In order to study how the loss of alpha catenin can impair liver regeneration and cause a cholestatic response, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on rat samples (fig 3). Sci Rep (2014) ncbi
rabbit polyclonal
  • western blot; mouse; fig 5
In order to investigate if and how mTOR regulates YAP, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on mouse samples (fig 5). J Exp Med (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human
  • western blot; human
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911S) was used in western blot on human samples at 1:1000. Cell (2014) ncbi
rabbit polyclonal
  • western blot; human
In order to investigate the expression and activity of receptor tyrosine kinases, MAP kinase, AKT, or Hippo pathways in human schwannomas, Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in western blot on human samples . Neuro Oncol (2014) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4a
Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples at 1:1000 (fig 4a). Nat Commun (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s6b
Cell Signaling Technology YAP1 antibody (cell signalling, 4911) was used in western blot on human samples at 1:1000 (fig s6b). Nat Cell Biol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 4c
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in immunocytochemistry on human samples (fig 4c) and in western blot on human samples (fig 1a). Oncogene (2015) ncbi
rabbit polyclonal
  • immunohistochemistry; mouse; 1:200
In order to study the repression of adult heart regeneration by Hippo signaling, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in immunohistochemistry on mouse samples at 1:200. Development (2013) ncbi
rabbit polyclonal
  • western blot; mouse
In order to study the role of Crumbs3 in proper epithelial development and viability, Cell Signaling Technology YAP1 antibody (Cell Signaling, 4911) was used in western blot on mouse samples . Mol Cell Biol (2014) ncbi
rabbit polyclonal
  • immunocytochemistry; human; 1:200; fig s1
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in immunocytochemistry on human samples at 1:200 (fig s1) and in western blot on human samples at 1:1000 (fig 1). J Invest Dermatol (2014) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig 1
Cell Signaling Technology YAP1 antibody (Cell Signaling Technology, 4911) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). PLoS Genet (2013) ncbi
Articles Reviewed
  1. Rong X, Han Q, Lin X, Kremerskothen J, Wang E. FRMPD1 activates the Hippo pathway via interaction with WWC3 to suppress the proliferation and invasiveness of lung cancer cells. Cancer Manag Res. 2019;11:3395-3410 pubmed publisher
  2. Rausch V, Bostrom J, Park J, Bravo I, Feng Y, Hay D, et al. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae. Curr Biol. 2019;29:242-255.e6 pubmed publisher
  3. Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton B, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun. 2018;9:2269 pubmed publisher
  4. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  5. Ibar C, Kirichenko E, Keepers B, Enners E, Fleisch K, Irvine K. Tension-dependent regulation of mammalian Hippo signaling through LIMD1. J Cell Sci. 2018;131: pubmed publisher
  6. Lu L, Finegold M, Johnson R. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp Mol Med. 2018;50:e423 pubmed publisher
  7. Kim J, Kim Y, Kim J, Park D, Bae H, Lee D, et al. YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017;127:3441-3461 pubmed publisher
  8. Toloczko A, Guo F, Yuen H, Wen Q, Wood S, Ong Y, et al. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Cancer Res. 2017;77:4921-4933 pubmed publisher
  9. Lin C, Yao E, Zhang K, Jiang X, Croll S, Thompson Peer K, et al. YAP is essential for mechanical force production and epithelial cell proliferation during lung branching morphogenesis. elife. 2017;6: pubmed publisher
  10. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  11. Ragni C, Diguet N, Le Garrec J, Novotova M, Resende T, Pop S, et al. Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth. Nat Commun. 2017;8:14582 pubmed publisher
  12. Lee H, Diaz M, Price K, Ozuna J, Zhang S, Sevick Muraca E, et al. Fluid shear stress activates YAP1 to promote cancer cell motility. Nat Commun. 2017;8:14122 pubmed publisher
  13. Hirai M, Arita Y, McGlade C, Lee K, Chen J, Evans S. Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. J Clin Invest. 2017;127:569-582 pubmed publisher
  14. Nguyen H, Kugler J, Cohen S. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins. PLoS ONE. 2017;12:e0169587 pubmed publisher
  15. Jerić I, Maurer G, Cavallo A, Raguz J, Desideri E, Tarkowski B, et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nat Commun. 2016;7:13781 pubmed publisher
  16. Wang L, Luo J, Li B, Tian X, Chen L, Huang Y, et al. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Nature. 2016;540:579-582 pubmed publisher
  17. Moroishi T, Hayashi T, Pan W, Fujita Y, Holt M, Qin J, et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016;167:1525-1539.e17 pubmed publisher
  18. Kim W, Khan S, Gvozdenovic Jeremic J, Kim Y, Dahlman J, Kim H, et al. Hippo signaling interactions with Wnt/?-catenin and Notch signaling repress liver tumorigenesis. J Clin Invest. 2017;127:137-152 pubmed publisher
  19. Kim H, Kim M, Park Y, Park I, Kim T, Yang S, et al. Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice. Gastroenterology. 2017;152:616-630 pubmed publisher
  20. Matsumoto Y, La Rose J, Kent O, Wagner M, Narimatsu M, Levy A, et al. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. J Clin Invest. 2016;126:4482-4496 pubmed publisher
  21. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  22. Georgescu M, Gagea M, Cote G. NHERF1/EBP50 Suppresses Wnt-?-Catenin Pathway-Driven Intestinal Neoplasia. Neoplasia. 2016;18:512-23 pubmed publisher
  23. Vahid S, Thaper D, Gibson K, Bishop J, Zoubeidi A. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer. Sci Rep. 2016;6:31842 pubmed publisher
  24. Ruess D, Probst M, Marjanovic G, Wittel U, Hopt U, Keck T, et al. HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury. PLoS ONE. 2016;11:e0161233 pubmed publisher
  25. Reginensi A, Enderle L, Gregorieff A, Johnson R, Wrana J, McNeill H. A critical role for NF2 and the Hippo pathway in branching morphogenesis. Nat Commun. 2016;7:12309 pubmed publisher
  26. Fernando R, Cotter L, Perrin Tricaud C, Berthelot J, Bartolami S, Pereira J, et al. Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway. Nat Commun. 2016;7:12186 pubmed publisher
  27. Huang D, Li X, Sun L, Huang P, Ying H, Wang H, et al. Regulation of Hippo signalling by p38 signalling. J Mol Cell Biol. 2016;8:328-37 pubmed publisher
  28. Feng X, Liu P, Zhou X, Li M, Li F, Wang Z, et al. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration. J Biol Chem. 2016;291:18947-58 pubmed publisher
  29. Huang Z, Hu J, Pan J, Wang Y, Hu G, Zhou J, et al. YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation. Development. 2016;143:2398-409 pubmed publisher
  30. Simile M, Latte G, Demartis M, Brozzetti S, Calvisi D, Porcu A, et al. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. Oncotarget. 2016;7:49194-49216 pubmed publisher
  31. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  32. Ni T, Kuperwasser C. Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer. elife. 2016;5: pubmed publisher
  33. McKey J, Martire D, de Santa Barbara P, Faure S. LIX1 regulates YAP1 activity and controls the proliferation and differentiation of stomach mesenchymal progenitors. BMC Biol. 2016;14:34 pubmed publisher
  34. Lodge E, Russell J, Patist A, Francis West P, Andoniadou C. Expression Analysis of the Hippo Cascade Indicates a Role in Pituitary Stem Cell Development. Front Physiol. 2016;7:114 pubmed publisher
  35. Thongon N, Castiglioni I, Zucal C, Latorre E, D Agostino V, Bauer I, et al. The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level. Oncotarget. 2016;7:26551-66 pubmed publisher
  36. Keyvani Chahi A, Martin C, Jones N. Nephrin Suppresses Hippo Signaling through the Adaptor Proteins Nck and WTIP. J Biol Chem. 2016;291:12799-808 pubmed publisher
  37. Ma B, Cheng H, Gao R, Mu C, Chen L, Wu S, et al. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Nat Commun. 2016;7:11123 pubmed publisher
  38. Grampa V, Delous M, Zaidan M, Odye G, Thomas S, Elkhartoufi N, et al. Novel NEK8 Mutations Cause Severe Syndromic Renal Cystic Dysplasia through YAP Dysregulation. PLoS Genet. 2016;12:e1005894 pubmed publisher
  39. Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498 pubmed publisher
  40. Liu X, Li H, Rajurkar M, Li Q, Cotton J, Ou J, et al. Tead and AP1 Coordinate Transcription and Motility. Cell Rep. 2016;14:1169-1180 pubmed publisher
  41. Dai X, Zhuang L, Wang D, Zhou T, Chang L, Gai R, et al. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells. Oncotarget. 2016;7:6933-47 pubmed publisher
  42. Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, et al. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci U S A. 2016;113:E71-80 pubmed publisher
  43. Giampietro C, Disanza A, Bravi L, Barrios Rodiles M, Corada M, Frittoli E, et al. The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling. J Cell Biol. 2015;211:1177-92 pubmed publisher
  44. Kim M, Kim M, Park S, Lee C, Lim D. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. EMBO Rep. 2016;17:64-78 pubmed publisher
  45. Meng Z, Moroishi T, Mottier Pavie V, Plouffe S, Hansen C, Hong A, et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun. 2015;6:8357 pubmed publisher
  46. Plescher M, Teleman A, Demetriades C. TSC2 mediates hyperosmotic stress-induced inactivation of mTORC1. Sci Rep. 2015;5:13828 pubmed publisher
  47. Noritake K, Aki T, Funakoshi T, Unuma K, Uemura K. Direct Exposure to Ethanol Disrupts Junctional Cell-Cell Contact and Hippo-YAP Signaling in HL-1 Murine Atrial Cardiomyocytes. PLoS ONE. 2015;10:e0136952 pubmed publisher
  48. Archibald A, Al Masri M, Liew Spilger A, McCaffrey L. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling. Mol Biol Cell. 2015;26:3578-95 pubmed publisher
  49. Zoch A, Mayerl S, Schulz A, Greither T, Frappart L, Rübsam J, et al. Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation. PLoS ONE. 2015;10:e0129151 pubmed publisher
  50. Choi H, Zhang H, Park H, Choi K, Lee H, Agrawal V, et al. Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2. Nat Commun. 2015;6:6943 pubmed publisher
  51. Tanas M, Ma S, Jadaan F, Ng C, Weigelt B, Reis Filho J, et al. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein. Oncogene. 2016;35:929-38 pubmed publisher
  52. Iglesias Bartolomé R, Torres D, Marone R, Feng X, Martin D, Simaan M, et al. Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol. 2015;17:793-803 pubmed publisher
  53. Meena J, Cerutti A, Beichler C, Morita Y, Bruhn C, Kumar M, et al. Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion. EMBO J. 2015;34:1371-84 pubmed publisher
  54. Dong C, Wei K, Zhang W, Sun H, Pan H, Zhang L. LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma. J Oral Pathol Med. 2015;44:475-81 pubmed publisher
  55. Mo J, Meng Z, Kim Y, Park H, Hansen C, Kim S, et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17:500-10 pubmed publisher
  56. Machado Neto J, Lazarini M, Favaro P, de Melo Campos P, Scopim Ribeiro R, Franchi Junior G, et al. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. Biochim Biophys Acta. 2015;1853:583-93 pubmed publisher
  57. Li Q, Li S, Mana Capelli S, Roth Flach R, Danai L, Amcheslavsky A, et al. The conserved misshapen-warts-Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev Cell. 2014;31:291-304 pubmed publisher
  58. Ma B, Chen Y, Chen L, Cheng H, Mu C, Li J, et al. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol. 2015;17:95-103 pubmed publisher
  59. Serinagaoglu Y, Paré J, Giovannini M, Cao X. Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development. Dev Biol. 2015;398:97-109 pubmed publisher
  60. Kim M, Kim M, Lee M, Kim C, Lim D. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis. Nat Commun. 2014;5:5370 pubmed publisher
  61. Herr K, Tsang Y, Ong J, Li Q, Yap L, Yu W, et al. Loss of α-catenin elicits a cholestatic response and impairs liver regeneration. Sci Rep. 2014;4:6835 pubmed publisher
  62. Liang N, Zhang C, Dill P, Panasyuk G, Pion D, Koka V, et al. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. J Exp Med. 2014;211:2249-63 pubmed publisher
  63. Xia Y, Chang T, Wang Y, Liu Y, Li W, Li M, et al. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. PLoS ONE. 2014;9:e91770 pubmed publisher
  64. Mori M, Triboulet R, Mohseni M, Schlegelmilch K, Shrestha K, Camargo F, et al. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell. 2014;156:893-906 pubmed publisher
  65. Boin A, Couvelard A, Couderc C, Brito I, Filipescu D, Kalamarides M, et al. Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas. Neuro Oncol. 2014;16:1196-209 pubmed publisher
  66. Shao D, Zhai P, Del Re D, Sciarretta S, Yabuta N, Nojima H, et al. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response. Nat Commun. 2014;5:3315 pubmed publisher
  67. Piao H, Yuan Y, Wang M, Sun Y, Liang H, Ma L. ?-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-?B signalling. Nat Cell Biol. 2014;16:245-54 pubmed publisher
  68. Tanaka I, Osada H, Fujii M, Fukatsu A, Hida T, Horio Y, et al. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade. Oncogene. 2015;34:73-83 pubmed publisher
  69. Heallen T, Morikawa Y, Leach J, Tao G, Willerson J, Johnson R, et al. Hippo signaling impedes adult heart regeneration. Development. 2013;140:4683-90 pubmed publisher
  70. Whiteman E, Fan S, Harder J, Walton K, Liu C, Soofi A, et al. Crumbs3 is essential for proper epithelial development and viability. Mol Cell Biol. 2014;34:43-56 pubmed publisher
  71. Nallet Staub F, Marsaud V, Li L, Gilbert C, Dodier S, Bataille V, et al. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma. J Invest Dermatol. 2014;134:123-132 pubmed publisher
  72. Reginensi A, Scott R, Gregorieff A, Bagherie Lachidan M, Chung C, Lim D, et al. Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet. 2013;9:e1003380 pubmed publisher